mRNA degradation in Mycobacterium tuberculosis with DosR ectopically induced

mRNA degradation in Mycobacterium tuberculosis under aerobic conditions

mRNA degradation in Mycobacterium tuberculosis during cold and hypoxic stress

mRNA degradation in Mycobacterium tuberculosis

WhiB6 is required for the secretion-dependent regulation of ESX-1 substrates in pathogenic mycobacteria

WhiB1 transcriptone in response to NO stress

Vitamin C Stimulon in Mycobacterium tuberculosis

Validation of RelMtb as a target for Mycobacterium tuberculosis persisters

Transcriptomic changes associated with the depletion of RNA degradosome components PNPase, RNase E and RNase J in Mycobacterium tuberculosis.

Transcriptomic changes associated with growth of Mycobacterium tuberculosis H37Rv wild-type strain and ∆prpR mutant in mineral medium supplemented with cholesterol as the sole carbon source or standard medium supplemented with vitamin B12.

Transcriptomic changes associated with deletion of Rv3143 from Mycobacterium tuberculosis H37Rv in relation to wild-type strain grown in 7H9/OADC medium

Transcriptomic analysis of untreated log-phase Mtb H37Rv, Mtbrv0158 Knockout strain and Mtbrv0158 complemented strain

Transcriptomic analysis of Wt Mtb H37Rv and WhiB4 Complemented strains on treatment with 0.25 mM Cumene hydroperoxide (CHP) for 2 h at 37°C.

Transcriptomic analysis of Wild type M.tb H37Rv, HigB KO M.tb H37Rv and complemented Hig B KO M.tb H37Rv

Transcriptomic analysis of Mtb H37Rv on treatment with ATD-3169 (Redox generating compound)

Transcriptomic analysis of Mtb H37Rv and MtbΔwhiB4 on treatment to 10X Augmentin (AG) i.e. combination of 100 µg/ml of Amoxicillin and 8 µg/ml of Clavulanate and lower Augmentin doses at 1X and 5X

Transcriptomic analysis of Mtb H37Rv and MtbΔwhiB3 at pH 4.5

Transcriptomic analysis of Mtb H37Rrv and MtbΔwhiB4 upon treatment with 0.25 mM CHP

Transcriptomic analysis of Mtb Erdman, MtbΔvirS and MtbΔvirSComplement upon acidic stress of pH4.5

Transcriptome profiling of Mycobacterium tuberculosis H37Rv to primary drugs